Biopharmaceutical company.
Education and outreach about the competitive elements of the Medicare Part D drug benefit and opposition to legislation imposing Medicaid style manufacturer rebates in the program. H.R. 3723: Viral Hepatitis Testing Act.
Implementation of Affordable Care Act as it relates to a regulatory pathway for biosimilars.
Legislative efforts to help accelerate the discovery, development and delivery of promising new treatments to patients (21st Century Cures).Education about the value of innovative new medicines.
Proposed changes to generic drug labeling. Monitored legislative efforts to reform the corporate tax system.
S. 2360/H.R. 4679:  Stop Corporate Inversion Act of 2014.
MMM - Medicare/Medicaid HCR - Health Issues TAX - Taxation/Internal Revenue Code
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
W STRATEGIES, LLC
1455 Pennsylvania Avenue, NW, Suite 400, Washington, DC, 20004, US
DARREN WILLCOX DARREN WILLCOX DARREN WILLCOX